Search

everythinglearnresearchcommunity

for

Search:↓

Hair follicles may help teach the immune system to tolerate new self-antigens, but this can sometimes cause hair loss.

Higher free testosterone levels in men are linked to a stronger immune response, not weaker.

Restoring hair follicle immune privilege may help treat alopecia areata.

Sex hormone antibodies can help identify male and female contributors in forensic samples.

IVIG therapy significantly improved symptoms in a patient with APS-2 and SPS.

Rituximab therapy successfully treated a patient's complete body hair loss and was effective for six years.

ILC1-like cells can cause alopecia areata by disrupting hair follicle immunity, suggesting a new treatment approach.

Patients with severe alopecia areata have higher levels of MIF, which decrease after successful treatment.

Mast cell and nerve fiber interactions in mouse skin change with the hair cycle.

Breast implants are linked to autoimmune symptoms, with over half of patients feeling better after removal, but the exact cause is unclear and may involve bacterial biofilm.

Blocking certain proteins on immune cells may help treat alopecia areata.

A humanized IL-2 fusion protein boosts T regulatory cells and helps control hair loss in Alopecia Areata.

The study found that a key immune pathway protecting hair follicles is reduced in a mouse model of scarring hair loss.

A woman with a drug allergy to anakinra was successfully desensitized, allowing her to continue treatment without allergic reactions.

ILC1-like cells may contribute to hair loss in alopecia areata.

A method was developed to isolate and study hair follicle stem cells from mouse skin.

Somatostatin helps hair follicles suppress immune responses, which might aid in treating certain hair loss conditions.

Targeted immune modulation can help achieve stable remission in alopecia areata.

IVIg treatment improved symptoms but caused permanent dark hair loss.

Combining imiquimod with diphenylcyclopropenone may improve treatment outcomes for alopecia areata patients who don't respond to diphenylcyclopropenone alone.

Hair regrowth in alopecia universalis may be possible by altering immune cells.

Immunosuppression therapy with methylprednisolone effectively treats childhood alopecia areata.

Follicular dystrophy in immunocompromised patients may be linked to medication or viral factors and can improve with treatment changes.

SLE patients need careful diagnosis to distinguish infections from disease flares for proper treatment.

Anti-Desmocollin 3 antibodies can cause atypical pemphigus symptoms.

A woman with lupus had blood cell destruction, treated successfully with medication.

Neoplasms hide in hair follicles to avoid the immune system.

Certain immune cells are linked to non-scarring hair loss, suggesting potential for immune-targeted treatments.